Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1995 3
1996 3
1998 3
1999 2
2000 1
2001 1
2002 1
2020 1
2021 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
TLR2-mediated innate immune priming boosts lung anti-viral immunity.
Girkin J, Loo SL, Esneau C, Maltby S, Mercuri F, Chua B, Reid AT, Veerati PC, Grainge CL, Wark PAB, Knight D, Jackson D, Demaison C, Bartlett NW. Girkin J, et al. Among authors: demaison c. Eur Respir J. 2021 Jul 1;58(1):2001584. doi: 10.1183/13993003.01584-2020. Print 2021 Jul. Eur Respir J. 2021. PMID: 33303547 Free article.
TLR2-mediated activation of innate responses in the upper airways confers antiviral protection of the lungs.
Deliyannis G, Wong CY, McQuilten HA, Bachem A, Clarke M, Jia X, Horrocks K, Zeng W, Girkin J, Scott NE, Londrigan SL, Reading PC, Bartlett NW, Kedzierska K, Brown LE, Mercuri F, Demaison C, Jackson DC, Chua BY. Deliyannis G, et al. Among authors: demaison c. JCI Insight. 2021 Mar 8;6(5):e140267. doi: 10.1172/jci.insight.140267. JCI Insight. 2021. PMID: 33561017 Free PMC article.
The COPD Foundation's COPD360Net Initiative Approach to Patient-Centric Drug Development: A Case Study in Using Patient Surveys to Inform New Treatments for Viral Respiratory Infections.
Tal-Singer R, Miller BE, Rommes JM, Luttmann MA, Demaison C, Bradley Drummond M, Pasquale CB. Tal-Singer R, et al. Among authors: demaison c. J Patient Exp. 2023 Jan 26;10:23743735231151554. doi: 10.1177/23743735231151554. eCollection 2023. J Patient Exp. 2023. PMID: 36741822 Free PMC article.
Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model.
Proud PC, Tsitoura D, Watson RJ, Chua BY, Aram MJ, Bewley KR, Cavell BE, Cobb R, Dowall S, Fotheringham SA, Ho CMK, Lucas V, Ngabo D, Rayner E, Ryan KA, Slack GS, Thomas S, Wand NI, Yeates P, Demaison C, Zeng W, Holmes I, Jackson DC, Bartlett NW, Mercuri F, Carroll MW. Proud PC, et al. Among authors: demaison c. EBioMedicine. 2021 Jan;63:103153. doi: 10.1016/j.ebiom.2020.103153. Epub 2020 Dec 3. EBioMedicine. 2021. PMID: 33279857 Free PMC article.
Dysregulation of interleukin-2 receptor beta and interleukin-2 receptor gamma expression during HIV infection.
David D, Bani L, Moreau JL, Treilhou MP, Demaison C, Sun K, Février M, Salvucci O, Cayota A, Nakarai T, Chouaïb S, de Montalembert M, Joussemet M, Sugamura K, Ritz J, Dupont B, Pialoux G, Thèze J. David D, et al. Among authors: demaison c. Eur Cytokine Netw. 1998 Sep;9(3 Suppl):97-101. Eur Cytokine Netw. 1998. PMID: 9831196 Review. No abstract available.
20 results